Hyperprolactinemia and amenorrhea associated with olanzapine normalized after addition of aripiprazole

Journal of Clinical Pharmacy and Therapeutics

Volumn 32, Issue 2, 2007, Pages 197-198

  Wolf, J ^a   Fiedler, U ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Aripiprazole; Combination; Hyperprolactinemia; Olanzapine; Schizophrenia

Indexed keywords

ARIPIPRAZOLE; CITALOPRAM; MIRTAZAPINE; OLANZAPINE; PROLACTIN;

ADULT; AMENORRHEA; ARTICLE; CASE REPORT; DEPRESSION; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG EFFECT; FEMALE; HUMAN; HYPERPROLACTINEMIA; PROLACTIN BLOOD LEVEL; SCHIZOPHRENIA;

ADULT; AMENORRHEA; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPERPROLACTINEMIA; PIPERAZINES; QUINOLONES;

EID: 33947430556     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2007.00806.x     Document Type: Article

References (10)

1. Goodnick PJ, Jerry JM (2002) Aripiprazole: profile on efficacy and safety. Expert Opinion on Pharmacotherapy, 3, 1773-1781. Rev.
2. Stimmel GL et al. (2002) Ziprasidone: an atypical antipsychotic drug for the treatment of schizophrenia. Clinical Therapeutics, 24, 21-37.
3. Inoue A et al. (1998) Differential effects on D2-dopamine receptor and prolactin gene expression by haloperidol and aripiprazole in the rat pituitary. Molecular Brain Research, 55, 285-292.
4. Petty RG (1999) Prolactin and antipsychotic medication: mechanism of action. Schizophrenia Research, 35, 67-73.
5. Anghelescu I, Wolf J (2004) Successful switch to aripiprazole after induction of hyperprolactinemia by ziprasidone: a case report. Journal of Clinical Psychiatry 65, 1286-1287.
6. Compton MT, Miller AH (2002) Antipsychotic-induced Hyperprolactinemia and sexual dysfunction. Psychopharmacology Bulletin 36, 143-164.
7. Baumann P et al. (2004) The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry. Pharmacopsychiatry 37, 243-265.
8. Marder SR, Mc Quade RD, Stock E et al. (2003) Aripiprazole in the treatment of schizophrenia: safety and tolerability in the short-term placebo-controlled trials. Schizophrenia Research 1916, 1-14.
9. Pigott TA, Carson WH, Saha AR (2003) Aripirazole for the prevention of relapse in stabilized patients with chronic schizophrenia: a placebo-controlled 26-week study. Journal of Clinical Psychology 64, 1048-1056.
10. Karunakara K, Tungaraza TE, Harborne G (2006) Is clozapine-aripiprazole combination a useful regime in the management of treatment-resistant schizophrenia? Journal of Psychopharmacology, Oct 18; Epub ahead of print.